-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on CG Oncology, Raises Price Target to $113

Benzinga·11/17/2026 18:39:03
JP Morgan analyst Brian Cheng maintains CG Oncology (NASDAQ:CGON) with a Overweight and raises the price target from $96 to $113.